NSE filing, NSE: KRONOX. Summary written from the filing by ALFA Finder's alert engine.
Kronox Lab Sciences Ltd: key numbers
- Share price
- ₹196.48
- Market cap
- ₹729.0 Cr
- Revenue (annual)
- ₹101.2 Cr
- Net profit (annual)
- ₹27.66 Cr
- P/E (TTM)
- 25.5×Sector 34.5×
- Promoter holding
- 64.26%-9.95% QoQ
- FII holding
- 0.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kronox Lab Sciences Ltd
All →Kronox Lab Sciences Change in Control
Kronox Lab Sciences' share purchase agreement with Indo Borax was amended on October 22, 2026. The amendment deletes the seller lock-in and right of first refusal clauses.
Kronox Lab Sciences Other Announcement
Kronox Lab Sciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Kronox Lab Sciences Acquisition
Kronox Lab Sciences Limited approved the acquisition of a 5,000 sq. meter manufacturing plant in Dahej SEZ from Axiom Chemicals Private Limited to expand capacity.
- Execution
- Within one month
- plant size
- 5000.0 Sq. meters
Kronox Lab Sciences Promoter Selling (Off-Market): ₹246.1 Cr
Three promoters (Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani) sold equity shares totaling Rs. 246.12 Crore through off-market transactions.
- Value
- ₹246.1 Cr
Kronox Lab Sciences Promoter Selling (Off-Market): ₹88.42 Cr
Promoter Jogindersingh Jaswal sold 9,796,400 equity shares of Kronox Lab Sciences, representing a 23.09% stake, for ₹88.42 Crore via an off-market transaction.
- Value
- ₹88.42 Cr
Kronox Lab Sciences Business Update
Kronox Lab Sciences has entered into a consultancy agreement with outgoing promoter Jogindersingh Jaswal to provide transition support services in research, development, and production.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.